ÂÜÀòÂÒÂ×

Andrew Jenner serves as Director General at INTERPAT since September 2017, focusing on fostering consensus among Intellectual Property leaders in the biopharmaceutical sector to enhance global health innovation. As Executive Director at JS Consulting Ltd. since January 2015, Andrew Jenner supports diverse clients across strategic and public affairs, particularly addressing issues such as Antimicrobial Resistance and COVID-19. Additionally, Andrew Jenner acts as Special Advisor to the Director General at IFPMA, contributing to corporate strategy on global health policy matters. Previous roles include leadership positions at EFPIA, UK IPO, and extensive experience as a patent examiner. Andrew Jenner holds an LL.M. in Intellectual Property Law and a PgD in Law & Intellectual Property, complemented by a B.Eng. in Mechanical Engineering.